Lower Dose of Mpox Vaccine Is Safe and Generates Six-Week Antibody Response Equivalent to Standard Regimen Study Highlights Need for Defined Markers of Mpox Immunity to Inform Public Health Use April 27, 2024

https://www.niaid.nih.gov/news-events/lower-dose-mpox-vaccine-safe-and-generates-six-week-antibody-response-equivalent?utm_campaign=+60383315&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=